Bacterial cellulose (BC) has established to be a remarkably versatile biomaterial and can be used in a wide variety of applied scientific endeavours, especially for medical devices. Nanocellulose, such as that produced by the bacteria Gluconacetobacter xylinus (bacterial cellulose, BC), is an emerging biomaterial with great potential in flexible radar absorbing materials, in scaffold for tissue regeneration, water treatment, and medical applications. Bacterial cellulose nanofibril bundles have excellent intrinsic properties due to their high crystallinity, which is higher than that generally recorded for macroscale natural fibers and is of the same order as the elastic modulus of glass fibers. Compared with cellulose from plants, BC also possesses higher water holding capacity, higher degree of polymerization (up to 8000), and a finer weblike network. In addition, BC is produced as a highly hydrated and relatively pure cellulose membrane, and therefore no chemical treatments are needed to remove lignin and hemicelluloses, as is the case for plant cellulose. Because of these characteristics, biomedical devices recently have gained a significant amount of attention because of an increased interest in tissue-engineered products for both wound care and the regeneration of damaged or diseased organs. Hydrophilic bacterial cellulose fibers of an average diameter of 50 nm are produced by the bacterium Acetobacter xylinum, using a fermentation process. The architecture of BC materials can be engineered over length scales ranging from nano to macro by controlling the biofabrication process. Moreover, the nanostructure and morphological similarities with collagen make BC attractive for cell immobilization and cell support. This review describes the fundamentals, purification, and morphological investigation of bacterial cellulose. Besides, microbial cellulose modification and how to increase the compatibility between cellulosic surfaces and a variety of plastic materials have been reported. Furthermore, provides deep knowledge of current and future applications of bacterial cellulose and their nanocomposites especially in the medical field.
Bacterial cellulose (BC) can be used in wide area of applied scientific, especially for tissue regeneration and regenerative medicine, lately, bacterial cellulose mats are used in the treatment of skin conditions such as burns and ulcers, because of the morphology of fibrous biopolymers serving as a support for cell proliferation, its pores allow gas exchange between the organism and the environment. Moreover, the nanostructure and morphological similarities with collagen make BC attractive for cell immobilization, cell support and Natural Extracellular Matrix (ECM) Scaffolds. In this scope, Natural ECM is the ideal biological scaffold since it contains all the components of the tissue. The development of mimicking biomaterials and hybrid biomaterial can further advance directed cellular differentiation without specific induction. The extracellular matrix (ECM) contains several signals that are received by cell surface receptors and contribute to cell adhesion and cell fate which control cellular activities such as proliferation, migration and differentiation. As such, regenerative medicine studies often rely on mimicking the natural ECM to promote the formation of new tissue by host cells, and characterization of natural ECM components is vital for the development of new biomimetic approaches. In this work, the bacterial cellulose fermentation process is modified by the addition of vegetal stem cell to the culture medium and natural materials before the bacteria are inoculated. In vivo behavior using natural ECM for regenerative medicine is presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.